NovaBay Pharmaceuticals Inc. (NYSE AMERICAN: NBY) Stock Information | RedChip

NovaBay Pharmaceuticals Inc. (NYSE AMERICAN: NBY) Listen to this Section


$0.53
+0.0428 ( +8.70% ) 702.8K

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.

Market Data


Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
10-k/a Quarterly Reports 18 Mar 29, 2024
8-k 8K-related 14 Mar 26, 2024
10-k Annual reports 115 Mar 26, 2024
8-k 8K-related 18 Mar 25, 2024
8-k 8K-related 18 Mar 14, 2024
8-k 8K-related 17 Jan 10, 2024
8-k 8K-related 16 Dec 21, 2023
8-k 8K-related 14 Dec 11, 2023
10-q Quarterly Reports 97 Nov 09, 2023
10-q Quarterly Reports 98 Aug 10, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.